Although high expression of EGFR is anticipated in HNSCC, lack of literature consistency regarding its effect on metastasis and survival may be due to diverse staining and isolation techniques, different quantitative biomarker thresholds, or a lack of objective or automated biomarker quantification. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.